RU2006105338A - 3, 4-SUBSTITUTED 1H-PYRAZOLIC COMPOUNDS AND THEIR APPLICATION AS CYCLINE-DEPENDENT KINASES (CDK) AND Glycogen Synthase KINASE-3 (GSK-3) MODULATORS - Google Patents
3, 4-SUBSTITUTED 1H-PYRAZOLIC COMPOUNDS AND THEIR APPLICATION AS CYCLINE-DEPENDENT KINASES (CDK) AND Glycogen Synthase KINASE-3 (GSK-3) MODULATORS Download PDFInfo
- Publication number
- RU2006105338A RU2006105338A RU2006105338/04A RU2006105338A RU2006105338A RU 2006105338 A RU2006105338 A RU 2006105338A RU 2006105338/04 A RU2006105338/04 A RU 2006105338/04A RU 2006105338 A RU2006105338 A RU 2006105338A RU 2006105338 A RU2006105338 A RU 2006105338A
- Authority
- RU
- Russia
- Prior art keywords
- group
- groups
- hydrogen
- optionally substituted
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
The invention provides compounds of the formula (0) or salts or tautomers or N-oxides or solvates thereof for use in the prophylaxis or treatment of disease states and conditions such as cancers mediated by cyclin-dependent kinase and glycogen synthase kinase-3. In formula (0): X is a group R1-A-NR4-or a 5-or 6-membered carbocyclic or heterocyclic ring; A is a bond, SO2, C=O, NRg(C=O) or O(C=O) wherein Rg is hydrogen or C1-4 hydrocarbyl optionally substituted by hydroxy or C1-4 alkoxy; Y is a bond or an alkylene chain of 1, 2 or 3 carbon atoms in length; R1 is hydrogen; a carbocyclic or heterocyclic group having from 3 to 12 ring members; or a C1-8 hydrocarbyl group optionally substituted by one or more substituents selected from halogen (e.g. fluorine), hydroxy, C1-4 hydrocarbyloxy, amino, mono- or di-C1-4 hydrocarbylamino, and carbocyclic or heterocyclic groups having from 3 to 12 ring members, and wherein 1 or 2 of the carbon atoms of the hydrocarbyl group may optionally be replaced by an atom or group selected from O, S, NH, SO, SO2; R2 is hydrogen; halogen; C1-4 alkoxy (e.g. methoxy); or a C1-4 hydrocarbyl group optionally substituted by halogen (e.g. fluorine), hydroxyl or C1-4 alkoxy (e.g. methoxy); R3 is selected from hydrogen and carbocyclic and heterocyclic groups having from 3 to 12 ring members; and R4 is hydrogen or a C1-4 hydrocarbyl group optionally substituted by halogen (e.g. fluorine), hydroxyl or C1-4 alkoxy (e.g. methoxy).
Claims (31)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48904603P | 2003-07-22 | 2003-07-22 | |
GB0317127.9 | 2003-07-22 | ||
US60/489,046 | 2003-07-22 | ||
GBGB0317127.9A GB0317127D0 (en) | 2003-07-22 | 2003-07-22 | Pharmaceutical compounds |
US60/569,763 | 2004-05-10 | ||
PCT/GB2004/003179 WO2005012256A1 (en) | 2003-07-22 | 2004-07-22 | 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2006105338A true RU2006105338A (en) | 2007-09-20 |
RU2408585C2 RU2408585C2 (en) | 2011-01-10 |
Family
ID=27772442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2006105338/04A RU2408585C2 (en) | 2003-07-22 | 2004-07-22 | 3,4-substituted 1h-pirazole compounds and their application as cyclin-dependant kinases (cdk) and modulators of glycogen synthase kinase-3 (gsk-3) |
Country Status (11)
Country | Link |
---|---|
CN (1) | CN1826323B (en) |
AT (1) | ATE553091T1 (en) |
DK (2) | DK1651612T5 (en) |
ES (2) | ES2539480T3 (en) |
GB (1) | GB0317127D0 (en) |
HU (1) | HUE025425T2 (en) |
PT (2) | PT2256106E (en) |
RU (1) | RU2408585C2 (en) |
SI (2) | SI1651612T1 (en) |
TW (1) | TWI356823B (en) |
ZA (1) | ZA200600313B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2762557C1 (en) * | 2018-04-26 | 2021-12-21 | Пфайзер Инк. | Derivatives of 2-aminopyridine or 2-aminopyrimidine as cyclin-dependent kinase inhibitors |
RU2790006C2 (en) * | 2018-04-26 | 2023-02-14 | Пфайзер Инк. | 2-aminopyridine or 2-aminopyrimidine derivatives as cyclin-dependent kinase inhibitors |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2947546B1 (en) * | 2009-07-03 | 2011-07-01 | Sanofi Aventis | PYRAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
EP2594555B1 (en) * | 2010-07-02 | 2018-03-07 | ASKA Pharmaceutical Co., Ltd. | HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
CN103012428A (en) * | 2013-01-08 | 2013-04-03 | 中国药科大学 | 4-(five-membered heterocycle pyrimidin/substituted pyridine) amino-1H-3-pyrazolecarboxamide CDK (cyclin dependent kinase)/Aurora dual inhibitor and application thereof |
CN104592251B (en) * | 2015-01-23 | 2019-10-01 | 上海复星医药产业发展有限公司 | 4- (condensed hetero ring substituted-amino) -1H- pyrazole-3-formamide class compound and application thereof |
EP3786164A1 (en) * | 2015-06-18 | 2021-03-03 | Ting Therapeutics LLC | Methods and compositions for the prevention and treatment of hearing loss |
CN107245073B (en) * | 2017-07-11 | 2020-04-17 | 中国药科大学 | 4- (aromatic heterocycle substituted) amino-1H-3-pyrazolecarboxamide FLT3 inhibitor and application thereof |
CN111848579B (en) * | 2019-04-26 | 2023-11-14 | 君实润佳(上海)医药科技有限公司 | Prodrugs of 4- (2, 6-dichlorobenzoylamino) -N- (4-piperidinyl) -1H-pyrazole-3-carboxamide |
-
2003
- 2003-07-22 GB GBGB0317127.9A patent/GB0317127D0/en not_active Ceased
-
2004
- 2004-07-22 AT AT04743512T patent/ATE553091T1/en active
- 2004-07-22 RU RU2006105338/04A patent/RU2408585C2/en not_active IP Right Cessation
- 2004-07-22 DK DK04743512.8T patent/DK1651612T5/en active
- 2004-07-22 PT PT101753291T patent/PT2256106E/en unknown
- 2004-07-22 ES ES10175329.1T patent/ES2539480T3/en active Active
- 2004-07-22 PT PT04743512T patent/PT1651612E/en unknown
- 2004-07-22 DK DK10175329.1T patent/DK2256106T3/en active
- 2004-07-22 SI SI200431891T patent/SI1651612T1/en unknown
- 2004-07-22 ES ES04743512T patent/ES2385328T3/en active Active
- 2004-07-22 SI SI200432244T patent/SI2256106T1/en unknown
- 2004-07-22 HU HUE10175329A patent/HUE025425T2/en unknown
- 2004-07-22 CN CN2004800211596A patent/CN1826323B/en not_active Expired - Fee Related
- 2004-07-22 TW TW093121972A patent/TWI356823B/en not_active IP Right Cessation
-
2006
- 2006-01-12 ZA ZA200600313A patent/ZA200600313B/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2762557C1 (en) * | 2018-04-26 | 2021-12-21 | Пфайзер Инк. | Derivatives of 2-aminopyridine or 2-aminopyrimidine as cyclin-dependent kinase inhibitors |
US11220494B2 (en) | 2018-04-26 | 2022-01-11 | Pfizer Inc. | Cyclin dependent kinase inhibitors |
RU2790006C2 (en) * | 2018-04-26 | 2023-02-14 | Пфайзер Инк. | 2-aminopyridine or 2-aminopyrimidine derivatives as cyclin-dependent kinase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
ZA200600313B (en) | 2007-02-28 |
ATE553091T1 (en) | 2012-04-15 |
ES2539480T3 (en) | 2015-07-01 |
CN1826323B (en) | 2012-06-27 |
RU2408585C2 (en) | 2011-01-10 |
DK2256106T3 (en) | 2015-06-01 |
ES2385328T3 (en) | 2012-07-23 |
TW200524877A (en) | 2005-08-01 |
GB0317127D0 (en) | 2003-08-27 |
DK1651612T5 (en) | 2012-10-22 |
PT2256106E (en) | 2015-07-22 |
HUE025425T2 (en) | 2016-02-29 |
SI1651612T1 (en) | 2012-09-28 |
CN1826323A (en) | 2006-08-30 |
PT1651612E (en) | 2012-07-06 |
TWI356823B (en) | 2012-01-21 |
SI2256106T1 (en) | 2015-10-30 |
DK1651612T3 (en) | 2012-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2412192C2 (en) | Sulphonamidethiazole pyridine derivatives as glucokinase activators, suitable for treating type-2 diabetes | |
US11267802B2 (en) | 2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method and use thereof | |
RU2007116038A (en) | CYCLIC DIARYM UREAS USED AS TYROSINKINASE INHIBITORS | |
EP2755958B1 (en) | Aminopyrimidine derivatives for use as modulators of kinase activity | |
RU2009134044A (en) | PHOSPHATIDYLINOSYTOL-3-KINASE INHIBITORS | |
JP2008528465A5 (en) | ||
JP2008528467A5 (en) | ||
RU2004132844A (en) | BENZAMIDE DERIVATIVES IMPAIRED AS HISTONIC DEACETHYLASE INHIBITORS | |
JP2018502877A5 (en) | ||
RU2015122414A (en) | Compounds of N-pyrrolidinyl urea, N'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine as TRKA kinase inhibitors | |
AU2018286361A1 (en) | N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer | |
RU2008141761A (en) | C-MET PROTEINKINASE INHIBITORS | |
ATE540933T1 (en) | PYRIMIDINE COMPOUNDS AS INTERLEUKIN-12 (IL-12) INHIBITORS | |
JP2007516194A5 (en) | ||
RU2008112221A (en) | COMPOUNDS OF A NUMBER OF ISOINDOLIMIDES, THEIR COMPOSITIONS AND METHODS OF APPLICATION | |
DE602004011199D1 (en) | 5-PHENYLTHIAZOL DERIVATIVES AND THEIR USE AS P13 KINASE INHIBITORS | |
HRP20140252T1 (en) | Imidazole derivatives as casein kinase inhibitors | |
PT1533304E (en) | Amide derivative | |
BR112021018704B1 (en) | HETEROARYL DERIVATIVE, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME AS AN EFFECTIVE COMPONENT | |
RU2007103706A (en) | CHINOLINTHIAZOLINONES WITH CDK1-ANTIPROLIFERATIVE ACTIVITY | |
WO2010007374A1 (en) | Pharmaceutical compounds | |
RU2006105338A (en) | 3, 4-SUBSTITUTED 1H-PYRAZOLIC COMPOUNDS AND THEIR APPLICATION AS CYCLINE-DEPENDENT KINASES (CDK) AND Glycogen Synthase KINASE-3 (GSK-3) MODULATORS | |
CA2489452A1 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
JP2017530139A (en) | Polycyclic inhibitors of anaplastic lymphoma kinase | |
AU2017342928A1 (en) | Quinoxaline compounds as type III receptor tyrosine kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20200723 |